Free Trial

Immatics (IMTXW) Competitors

Immatics logo
$0.01 0.00 (-11.54%)
As of 04/17/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IMTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Immatics vs.

Immatics (NASDAQ:IMTXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation.

Company Net Margins Return on Equity Return on Assets
ImmaticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Immatics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
ImmaticsN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Immatics$155.84MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Immatics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Immatics and 0 mentions for 180 Life Sciences. Immatics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that Immatics is being referred to more favorably in the media.

Company Overall Sentiment
Immatics Positive
180 Life Sciences Neutral

Summary

Immatics beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMTXW vs. The Competition

MetricImmaticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$120.88M$5.31B$7.34B
Dividend YieldN/A3.76%5.45%4.34%
P/E RatioN/A3.0521.9417.82
Price / SalesN/A4,157.44380.6697.73
Price / CashN/A13.0538.2534.64
Price / BookN/A34.176.453.98
Net IncomeN/A-$91.72M$3.22B$247.81M
7 Day PerformanceN/A1.39%0.74%0.28%
1 Month PerformanceN/A-6.39%-9.66%-7.60%
1 Year PerformanceN/A84.27%11.81%1.49%

Immatics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMTXW
Immatics
N/A$0.02
+41.5%
N/AN/A$0.00$155.84M0.00260Short Interest ↓
Positive News
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-2.5%
N/A-20.2%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+20.9%
N/A-80.5%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.09
+0.7%
N/A+97.8%$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.30
-13.9%
N/A-68.3%$0.00$489.68M0.004Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.07
+7.7%
N/AN/A$0.00$37.32M0.0070
BTMDW
biote
N/A$0.03
+17.0%
N/AN/A$0.00$197.19M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.08
-15.8%
N/A-93.1%$0.00N/A0.008Gap Down
CALA
Calithera Biosciences
N/A$0.00
-90.0%
N/A-80.0%$0.00N/A0.0060Gap Down

Related Companies and Tools


This page (NASDAQ:IMTXW) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners